Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase 2a Study of a Vaginal Ring Containing Dapivirine in Adolescent Females

Next Previous
X
Search
Trial Profile

Phase 2a Study of a Vaginal Ring Containing Dapivirine in Adolescent Females

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 25 Oct 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dapivirine (Primary)
  • Indications HIV infections
  • Focus Adverse reactions

    • Most Recent Events

    • 04 Dec 2021 Results (n=208) of exploratory analysis comparing the prevalence and concentration of specific microbiota before and after DPV ring use in three trials (NCT02028338, NCT02010593 and NCT02808949) conducted in adolescent, lactating, and postmenopausal women, published in the Journal of Infectious Diseases.
    • 01 Mar 2021 Results published in the JAIDS
    • 11 Nov 2020 Results assessing host proteome and microbiome changes in cervicovaginal mucus with dapivirine ring use in adolescents published in the AIDS

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top